• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢综合征在阿尔茨海默病发病机制中可能扮演的角色:支撑“双故事”的细胞及亚细胞改变

The Conceivable Role of Metabolic Syndrome in the Pathogenesis of Alzheimer's Disease: Cellular and Subcellular Alterations in Underpinning a Tale of Two.

作者信息

Alzarea Ekremah A, Al-Kuraishy Hayder M, Al-Gareeb Ali I, Alexiou Athanasios, Papadakis Marios, Beshay Olivia N, Batiha Gaber El-Saber

机构信息

Hematopathology, Department of Pathology, College of Medicine, Jouf University, Sakaka, Saudi Arabia.

Department of Clinical Pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad, Iraq.

出版信息

Neuromolecular Med. 2025 May 16;27(1):35. doi: 10.1007/s12017-025-08832-6.

DOI:10.1007/s12017-025-08832-6
PMID:40379890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12084261/
Abstract

Alzheimer's disease (AD)is an age-related neurodegenerative disease characterized by memory decline and cognitive impairment .AD is common in people aged > 65 years, though most of AD cases are sporadic, which accounts for 95%, and 1-5% of AD is caused by familial causes . The causes of AD are aging, environmental toxins, and cardiometabolic factors that induce the degeneration of cholinergic neurons. It has been shown that the metabolic syndrome which is a clustering of dissimilar constituents including insulin resistance (IR), glucose intolerance, visceral obesity, hypertension, and dyslipidemia is implicated in the pathogenesis of AD. Metabolic syndrome disapprovingly affects cognitive function and the development in AD by inducing the development of oxidative stress, neuroinflammation, and brain IR. These changes, together with brain IR, impair cerebrovascular reactivity causing cognitive impairment and dementia. Nevertheless, the fundamental mechanism by which metabolic syndrome persuades AD risk is not entirely explicated. Accordingly, this review aims to discuss the connotation between metabolic syndrome and AD. In conclusion, metabolic syndrome is regarded as a possible risk factor for the initiation of AD neuropathology by diverse signaling pathways such as brain IR, activation of inflammatory signaling pathways, neuroinflammation, defective proteostasis, and dysregulation of lipid mediators.

摘要

阿尔茨海默病(AD)是一种与年龄相关的神经退行性疾病,其特征为记忆力减退和认知障碍。AD在65岁以上人群中较为常见,尽管大多数AD病例为散发性,占95%,而1 - 5%的AD由家族性原因引起。AD的病因包括衰老、环境毒素以及导致胆碱能神经元变性的心脏代谢因素。研究表明,代谢综合征,即一种由胰岛素抵抗(IR)、葡萄糖不耐受、内脏肥胖、高血压和血脂异常等不同成分聚集而成的综合征,与AD的发病机制有关。代谢综合征通过诱导氧化应激、神经炎症和脑IR的发展,对AD的认知功能和病情发展产生不利影响。这些变化与脑IR一起,损害脑血管反应性,导致认知障碍和痴呆。然而,代谢综合征增加AD风险的根本机制尚未完全阐明。因此,本综述旨在探讨代谢综合征与AD之间的内在联系。总之,代谢综合征被认为是通过多种信号通路,如脑IR、炎症信号通路激活、神经炎症、蛋白稳态缺陷和脂质介质失调,引发AD神经病理学的一个可能危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb13/12084261/cfca1d801f4b/12017_2025_8832_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb13/12084261/f0deb253f7cc/12017_2025_8832_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb13/12084261/432339613842/12017_2025_8832_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb13/12084261/d726c5e2be63/12017_2025_8832_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb13/12084261/53284425b584/12017_2025_8832_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb13/12084261/bab7fdd588de/12017_2025_8832_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb13/12084261/f04a5db2f706/12017_2025_8832_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb13/12084261/cfca1d801f4b/12017_2025_8832_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb13/12084261/f0deb253f7cc/12017_2025_8832_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb13/12084261/432339613842/12017_2025_8832_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb13/12084261/d726c5e2be63/12017_2025_8832_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb13/12084261/53284425b584/12017_2025_8832_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb13/12084261/bab7fdd588de/12017_2025_8832_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb13/12084261/f04a5db2f706/12017_2025_8832_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb13/12084261/cfca1d801f4b/12017_2025_8832_Fig7_HTML.jpg

相似文献

1
The Conceivable Role of Metabolic Syndrome in the Pathogenesis of Alzheimer's Disease: Cellular and Subcellular Alterations in Underpinning a Tale of Two.代谢综合征在阿尔茨海默病发病机制中可能扮演的角色:支撑“双故事”的细胞及亚细胞改变
Neuromolecular Med. 2025 May 16;27(1):35. doi: 10.1007/s12017-025-08832-6.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Speech changes in old age: Methodological considerations for speech-based discrimination of healthy ageing and Alzheimer's disease.老年言语变化:基于言语的健康衰老与阿尔茨海默病鉴别方法学的考虑。
Int J Lang Commun Disord. 2024 Jan-Feb;59(1):13-37. doi: 10.1111/1460-6984.12888. Epub 2023 May 4.
4
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.马克 VCID 脑小血管联盟:一、入组、临床、液体方案。
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.
5
Recent advances in the detection and management of motor dysfunction in Alzheimer's disease.阿尔茨海默病运动功能障碍检测与管理的最新进展
Psychiatriki. 2025 May 14. doi: 10.22365/jpsych.2025.012.
6
Periodontitis-induced neuroinflammation triggers IFITM3-Aβ axis to cause alzheimer's disease-like pathology and cognitive decline.牙周炎诱导的神经炎症触发IFITM3-Aβ轴,导致阿尔茨海默病样病理改变和认知衰退。
Alzheimers Res Ther. 2025 Jul 19;17(1):166. doi: 10.1186/s13195-025-01818-3.
7
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
8
Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer's Disease and MCI: A Review.多因素方法逆转阿尔茨海默病和 MCI 认知衰退的理由:综述。
Int J Mol Sci. 2023 Jan 14;24(2):1659. doi: 10.3390/ijms24021659.
9
New insight on the potential detrimental effect of metabolic syndrome on the Alzheimer disease neuropathology: Mechanistic role.关于代谢综合征对阿尔茨海默病神经病理学潜在有害影响的新见解:作用机制
J Cell Mol Med. 2024 Dec;28(23):e70118. doi: 10.1111/jcmm.70118.
10
A Novel Design of a Portable Birdcage via Meander Line Antenna (MLA) to Lower Beta Amyloid (Aβ) in Alzheimer's Disease.一种通过曲折线天线(MLA)设计的便携式鸟笼,用于降低阿尔茨海默病中的β淀粉样蛋白(Aβ)。
IEEE J Transl Eng Health Med. 2025 Apr 10;13:158-173. doi: 10.1109/JTEHM.2025.3559693. eCollection 2025.

本文引用的文献

1
Emerging Role of Ubiquitin Proteasome System and Autophagy in Pediatric Demyelinating Leukodystrophies and Therapeutic Opportunity.泛素蛋白酶体系统和自噬在儿科脱髓鞘白质营养不良中的新兴作用和治疗机会。
Cells. 2024 Nov 12;13(22):1873. doi: 10.3390/cells13221873.
2
Proteostasis disruption and senescence in Alzheimer's disease pathways to neurodegeneration.阿尔茨海默病神经退行性变途径中的蛋白稳态失调和衰老。
Brain Res. 2024 Dec 15;1845:149202. doi: 10.1016/j.brainres.2024.149202. Epub 2024 Aug 30.
3
The duality of amyloid-β: its role in normal and Alzheimer's disease states.
淀粉样蛋白-β的双重性:在正常和阿尔茨海默病状态中的作用。
Mol Brain. 2024 Jul 17;17(1):44. doi: 10.1186/s13041-024-01118-1.
4
S-Nitrosoglutathione Attenuates Oxidative Stress and Improves Retention Memory Dysfunctions in Intra-Cerebroventricular-Streptozotocin Rat Model of Sporadic Alzheimer's Disease via Activation of BDNF and Nuclear Factor Erythroid 2-Related Factor-2 Antioxidant Signaling Pathway.S-亚硝基谷胱甘肽通过激活 BDNF 和核因子红细胞 2 相关因子-2 抗氧化信号通路,减轻氧化应激,改善散发性阿尔茨海默病脑室内注射链脲佐菌素大鼠模型的保留记忆功能障碍。
Neuropsychobiology. 2024;83(2):101-113. doi: 10.1159/000538348. Epub 2024 May 14.
5
Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico-pathological study.探讨伴或不伴糖尿病的高血压对阿尔茨海默病风险的影响:一项临床病理研究。
Alzheimers Dement. 2024 Apr;20(4):2766-2778. doi: 10.1002/alz.13717. Epub 2024 Feb 29.
6
Serum amyloid beta 42 levels correlated with metabolic syndrome and its components.血清淀粉样蛋白β 42 水平与代谢综合征及其组分相关。
Front Endocrinol (Lausanne). 2024 Feb 8;15:1278477. doi: 10.3389/fendo.2024.1278477. eCollection 2024.
7
Mitochondria in Alzheimer's Disease Pathogenesis.线粒体在阿尔茨海默病发病机制中的作用
Life (Basel). 2024 Jan 30;14(2):196. doi: 10.3390/life14020196.
8
Chitosan/PLA-loaded Magnesium oxide nanocomposite to attenuate oxidative stress, neuroinflammation and neurotoxicity in rat models of Alzheimer's disease.壳聚糖/PLA 负载氧化镁纳米复合材料减轻阿尔茨海默病大鼠模型的氧化应激、神经炎症和神经毒性。
Metab Brain Dis. 2024 Apr;39(4):487-508. doi: 10.1007/s11011-023-01336-x. Epub 2023 Dec 12.
9
Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer's disease.蛋白质稳态与神经退行性变:深入探讨阿尔茨海默病中的自噬
Front Aging Neurosci. 2023 Nov 2;15:1281338. doi: 10.3389/fnagi.2023.1281338. eCollection 2023.
10
The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer's disease: a new perspective.组织型纤溶酶原激活物/神经丝氨酸蛋白酶抑制剂轴在阿尔茨海默病中的可能作用:新视角。
Acta Neurol Belg. 2024 Apr;124(2):377-388. doi: 10.1007/s13760-023-02403-x. Epub 2023 Nov 2.